Bladder Cancer,Genitourinary Cancer APL-1202 +Tislelizumab: Exceeding pCR Rate Thresholds Mar 07, 2024
Bladder Cancer,Genitourinary Cancer Neoadjuvant NIVO & Nab-ABX in MIBC: NURE-Combo Study Feb 22, 2024
Bladder Cancer,Genitourinary Cancer MIBC: TMT With PD-1 Inhibitor and Hypo-Fractionated Radiation Jan 22, 2024
Bladder Cancer,Genitourinary Cancer EG-70: Promising Safety & Efficacy in High-Risk Bladder Cancer Jan 09, 2024
